TERF2 gene expression in childhood acute lymphoblastic leukaemia / Lelamekala Vengidasan
Advances in the understanding of cell biology in childhood acute lymphoblastic leukemia (cALL) have led to sophisticated risk-stratification based therapeutic interventions targeting individual patients. Despite these advances, approximately 10-20% of children with ALL still relapse. Thus, identific...
Saved in:
Main Author: | Vengidasan, Lelamekala |
---|---|
Format: | Thesis |
Published: |
2011
|
Subjects: | |
Online Access: | http://studentsrepo.um.edu.my/3832/5/Title_page%2C_abstract%2C_content.pdf http://studentsrepo.um.edu.my/3832/2/2._Chapter_1_%E2%80%93_6.pdf http://studentsrepo.um.edu.my/3832/3/3._Appendices.pdf http://studentsrepo.um.edu.my/3832/4/4._References.pdf http://pendeta.um.edu.my/client/default/search/results?qu=TERF2+gene+expression+in+childhood+acute+lymphoblastic+leukaemia&te= http://studentsrepo.um.edu.my/3832/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expression of telomeric repeat binding factor 2 (Terf2) in childhood acute lymphoblastic leukemia
by: Vengidasan, L., et al.
Published: (2021) -
HLA-haploidentical family donors: The new promise for childhood acute lymphoblastic leukaemia?
by: Ab Rahman, Syaza, et al.
Published: (2022) -
Decreased expression levels of natural killer cell-related genes in acute lymphoblastic leukaemia patients
by: Lee, Le Jie, et al.
Published: (2016) -
S-phase fraction and pro-inflammatory cytokine expressions in acute lymphoblastic leukaemia
by: Abdullah, Maha, et al.
Published: (2005) -
Effective Response Metric: a novel tool to predict relapse in childhood acute lymphoblastic leukaemia using time-series gene expression profiling
by: Yeoh, Allen Eng Juh, et al.
Published: (2018)